SOLARAPharmaceuticals
Solara Active Pharma Sciences Ltd — Quarterly Results & Earnings
₹425.55
-3.05%
Profit Growth YoY-226.09%Latest quarter
Sales Growth YoY-9.63%Latest quarter
Sales CAGR 5Y-0.58%5 year compound
Profit CAGR 5Y-65.77%5 year compound
📋
Quarterly Performance
YoY Profit Growth-226.09%
🔴 Significant decline
YoY Sales Growth-9.63%
⚠️ Mild contraction
OPM 5Y Average
10.32%Operating profit margin
EPS Growth 5Y
-65.82%Interest Coverage
1.06Higher = safer debt servicing
ROE
0.05%ROCE
6.01%💡
Growth Analysis
Solara Active Pharma Sciences Ltd reported YoY profit growth of -226.09% and revenue growth of -9.63% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -0.58% and profits at -65.77% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Solara Active Pharma Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.